-

IBM Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into International Business Machines Corporation (IBM)

IBM investors saw shares fall more than 24% after preliminary second-quarter results missed Wall Street expectations. The investigation focuses on the earnings miss, the market reaction, and whether IBM investors were exposed to losses tied to the July 14 selloff.

NEW YORK--(BUSINESS WIRE)--IBM (NYSE: IBM) shares fell nearly 25% on July 14, 2026, after the Company released preliminary second-quarter results that missed Wall Street expectations. Investors who held IBM through the earnings miss are reacting to a one-session loss tied directly to the Company’s reported results. Investors who lost money on IBM are encouraged to report your IBM losses today.

Levi & Korsinsky is investigating potential securities law violations following IBM’s July 14, 2026 market reaction. The Company’s preliminary second-quarter release also included reduced near-term revenue and earnings expectations, with the shortfall tied in part to a reduction in customer “capex spend toward servers, storage, and memory purchases to secure supply-constrained infrastructure ahead of expected price increases.”

Notably, during the previous earnings call on April 22, 2026, IBM’s Chief Financial Officer, James J. Kavanaugh, claimed the supply chain disruptions caused by “commodity price increases, in particular around memory” has a “de minimis impact to us overall. Think about mainframe overall.” Continuing, CEO Arvind Krishna added that IBM, as an early adopter of the “newest memory technologies,” is able to “somewhat mitigate some of these supply chain constraints.”

Send your IBM loss details or call (212) 363-7500.

ABOUT THE FIRM -- For over two decades, Levi & Korsinsky has represented shareholders in securities class actions. Ranked in ISS Top 50 for seven consecutive years.

Frequently Asked Questions About the IBM Investigation

Q: Who is eligible to participate in the IBM investigation? A: Investors who purchased IBM stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares.

Q: How much did IBM stock drop? A: IBM shares were falling approximately 24.5% after the Company released preliminary second-quarter results that missed Wall Street expectations and reduced near-term revenue and earnings expectations.

Q: Which statements are being investigated as potentially misleading? A: The investigation concerns IBM statements regarding revenue performance, earnings expectations, and AI-related spending trends before the July 14, 2026 stock decline.

Q: What documents do I need to participate? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any later sale dates and prices.

Q: What is a lead plaintiff and why does it matter? A: If the investigation proceeds to legal action, a lead plaintiff is the investor a court may appoint to represent affected investors. Lead plaintiffs are typically investors with the largest documented losses who are willing to serve.

Q: What if I already sold my IBM shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased and whether you suffered losses, not whether you still hold the shares.

Q: Do I need to go to court or give testimony? A: No. Participating in the investigation does not require court appearances or depositions. If legal action is later pursued, most affected investors do not appear in court.

Q: What does it cost me to participate? A: There is no upfront cost to participate. Securities investigations and any resulting proceedings are generally handled on a contingency basis, with no upfront fees, retainer, or out-of-pocket costs.

Attorney Advertising. Prior results do not guarantee similar outcomes.

Contacts

Levi & Korsinsky, LLP\
Joseph E. Levi, Esq.\
Ed Korsinsky, Esq.\
33 Whitehall Street, 27th Floor\
New York, NY 10004\
jlevi@levikorsinsky.com\
Tel: (212) 363-7500\
Fax: (212) 363-7171

Levi & Korsinsky

NYSE:IBM

Release Versions

Contacts

Levi & Korsinsky, LLP\
Joseph E. Levi, Esq.\
Ed Korsinsky, Esq.\
33 Whitehall Street, 27th Floor\
New York, NY 10004\
jlevi@levikorsinsky.com\
Tel: (212) 363-7500\
Fax: (212) 363-7171

More News From Levi & Korsinsky

ENVA Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Enova International (ENVA)

NEW YORK--(BUSINESS WIRE)--The bank charter applications Enova International (NYSE: ENVA) submitted to the Office of the Comptroller of the Currency and the Federal Reserve in January 2026 were withdrawn on September 14, 2026 -- and ENVA shares fell a sharp 22% overnight and continued to falter throughout the day. Investors who lost money on Enova International are encouraged to request a review of their ENVA losses. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com...

APP Shareholder Alert: November 16, 2026 Lead Plaintiff Deadline in AppLovin Corporation Securities Class Action - Contact Levi & Korsinsky

NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky, LLP tracks the evolution of Wall Street analyst opinion on AppLovin Corporation (NASDAQ: APP) and notifies investors that a securities class action was filed on behalf of shareholders who purchased securities between February 12, 2026 and August 5, 2026. Check if you might be eligible to recover your investment losses. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.APP closed at $335.67 on August 6, 2026, do...

DOCS Shareholder Alert: November 16, 2026 Lead Plaintiff Deadline in Doximity, Inc. Securities Class Action - Contact Levi & Korsinsky

NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky, LLP reminds purchasers of Doximity, Inc. (NYSE: DOCS) securities of a pending securities class action brought on behalf of investors who acquired shares between August 8, 2024 and May 13, 2026. Find out if you might qualify for recovery. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.DOCS shares declined $8.29 per share (13%) on November 7, 2025, $5.59 per share (17%) on February 6, 2026, and a further $5.38...
Back to Newsroom